CT colonography screening: Ready for prime time?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Every year more than one million new patients are diagnosed with colon cancer worldwide. Although multiple prospective randomized trials and observational studies have demonstrated that mortality from colon cancer can be reduced with screening and removal of adenomatous polyps, compliance with screening guidelines remains low. Recent CT colonography (CTC) trials have shown that CTC is capable of demonstrating adenomatous polyps -10mm (and in most cases -6 mm) with sensitivities comparable to those for optical colonoscopy. Based on these results, at least two expert panels have recommended CTC as an option for colorectal cancer screening. Despite these endorsements, the Centers for Medicare and Medicaid Services (CMS) in the United States recently decided to deny coverage of CTC for colorectal cancer screening. This article addresses the reservations raised by CMS and provides a perspective on whether CTC is ready for routine use as a colorectal cancer screening test.

Original languageEnglish (US)
JournalCancer Imaging
Volume9
Issue numberSPEC. ISS. A
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Computed Tomographic Colonography
Early Detection of Cancer
Adenomatous Polyps
Centers for Medicare and Medicaid Services (U.S.)
Colorectal Neoplasms
Colonic Neoplasms
Colonoscopy
Observational Studies
Guidelines
Mortality

Keywords

  • Colon, neoplasms
  • Colon, polyps
  • Colonoscopy
  • Computed tomography colonography
  • Rectum, neoplasms
  • Rectum, polyps
  • Virtual colonoscopy

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

CT colonography screening : Ready for prime time? / Heiken, Jay.

In: Cancer Imaging, Vol. 9, No. SPEC. ISS. A, 01.12.2009.

Research output: Contribution to journalArticle

@article{8365d5d6d0c24dbc9aab9734eddeb85c,
title = "CT colonography screening: Ready for prime time?",
abstract = "Every year more than one million new patients are diagnosed with colon cancer worldwide. Although multiple prospective randomized trials and observational studies have demonstrated that mortality from colon cancer can be reduced with screening and removal of adenomatous polyps, compliance with screening guidelines remains low. Recent CT colonography (CTC) trials have shown that CTC is capable of demonstrating adenomatous polyps -10mm (and in most cases -6 mm) with sensitivities comparable to those for optical colonoscopy. Based on these results, at least two expert panels have recommended CTC as an option for colorectal cancer screening. Despite these endorsements, the Centers for Medicare and Medicaid Services (CMS) in the United States recently decided to deny coverage of CTC for colorectal cancer screening. This article addresses the reservations raised by CMS and provides a perspective on whether CTC is ready for routine use as a colorectal cancer screening test.",
keywords = "Colon, neoplasms, Colon, polyps, Colonoscopy, Computed tomography colonography, Rectum, neoplasms, Rectum, polyps, Virtual colonoscopy",
author = "Jay Heiken",
year = "2009",
month = "12",
day = "1",
doi = "10.1102/1470-7330.2009.9025",
language = "English (US)",
volume = "9",
journal = "Cancer Imaging",
issn = "1740-5025",
publisher = "e-med",
number = "SPEC. ISS. A",

}

TY - JOUR

T1 - CT colonography screening

T2 - Ready for prime time?

AU - Heiken, Jay

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Every year more than one million new patients are diagnosed with colon cancer worldwide. Although multiple prospective randomized trials and observational studies have demonstrated that mortality from colon cancer can be reduced with screening and removal of adenomatous polyps, compliance with screening guidelines remains low. Recent CT colonography (CTC) trials have shown that CTC is capable of demonstrating adenomatous polyps -10mm (and in most cases -6 mm) with sensitivities comparable to those for optical colonoscopy. Based on these results, at least two expert panels have recommended CTC as an option for colorectal cancer screening. Despite these endorsements, the Centers for Medicare and Medicaid Services (CMS) in the United States recently decided to deny coverage of CTC for colorectal cancer screening. This article addresses the reservations raised by CMS and provides a perspective on whether CTC is ready for routine use as a colorectal cancer screening test.

AB - Every year more than one million new patients are diagnosed with colon cancer worldwide. Although multiple prospective randomized trials and observational studies have demonstrated that mortality from colon cancer can be reduced with screening and removal of adenomatous polyps, compliance with screening guidelines remains low. Recent CT colonography (CTC) trials have shown that CTC is capable of demonstrating adenomatous polyps -10mm (and in most cases -6 mm) with sensitivities comparable to those for optical colonoscopy. Based on these results, at least two expert panels have recommended CTC as an option for colorectal cancer screening. Despite these endorsements, the Centers for Medicare and Medicaid Services (CMS) in the United States recently decided to deny coverage of CTC for colorectal cancer screening. This article addresses the reservations raised by CMS and provides a perspective on whether CTC is ready for routine use as a colorectal cancer screening test.

KW - Colon, neoplasms

KW - Colon, polyps

KW - Colonoscopy

KW - Computed tomography colonography

KW - Rectum, neoplasms

KW - Rectum, polyps

KW - Virtual colonoscopy

UR - http://www.scopus.com/inward/record.url?scp=77649212394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649212394&partnerID=8YFLogxK

U2 - 10.1102/1470-7330.2009.9025

DO - 10.1102/1470-7330.2009.9025

M3 - Article

C2 - 19965295

AN - SCOPUS:77649212394

VL - 9

JO - Cancer Imaging

JF - Cancer Imaging

SN - 1740-5025

IS - SPEC. ISS. A

ER -